Growth Metrics

Inspire Medical Systems (INSP) Equity Ratio (2017 - 2025)

Inspire Medical Systems' Equity Ratio history spans 9 years, with the latest figure at 0.86 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 0.91% year-over-year to 0.86; the TTM value through Dec 2025 reached 0.86, up 0.91%, while the annual FY2025 figure was 0.86, 0.91% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.86 at Inspire Medical Systems, up from 0.83 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.89 in Q3 2022 and bottomed at 0.78 in Q4 2021.
  • The 5-year median for Equity Ratio is 0.85 (2023), against an average of 0.84.
  • The largest annual shift saw Equity Ratio fell 6.18% in 2021 before it grew 13.61% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.78 in 2021, then rose by 13.12% to 0.88 in 2022, then dropped by 3.67% to 0.85 in 2023, then grew by 0.86% to 0.85 in 2024, then rose by 0.91% to 0.86 in 2025.
  • Per Business Quant, the three most recent readings for INSP's Equity Ratio are 0.86 (Q4 2025), 0.83 (Q3 2025), and 0.84 (Q2 2025).